This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Damage Control Strategy for the Treatment of Perforated Diverticulitis of the Sigmoid Colon With Diffuse Peritonitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04220840
Recruitment Status : Recruiting
First Posted : January 7, 2020
Last Update Posted : September 8, 2023
Sponsor:
Collaborators:
Charite University, Berlin, Germany
Medical University Innsbruck
University of Pisa
Cardarelli Hospital
Information provided by (Responsible Party):
Dr. Maximilian Sohn, Städtisches Klinikum München GmbH

Brief Summary:

The best approach for the treatment of perforated diverticulitis of the sigmoid colon is still under debate. Concurrent techniques are 1) resection with primary colorectal anastomosis with or without additional loop ileostomy; 2) end colostomy (Hartmann´s procedure); 3) Damage control strategy; 4) laparoscopic lavage and placement of a drainage. It is hypothesized, that the use of the damage control strategy leads to a significant reduction of the stoma rate.

The damage control strategy constitutes a two stage procedure.

Emergency surgery:

limited resection of the diseased colonic segment with oral and aboral blind closure, abdominal lavage, temporary vacuum assisted abdominal closure

Second look surgery (48-72 hours later):

Reexploration with

  1. definite reconstruction (Colorectal anastomosis -/+ diverting ileostomy vs. end colostomy)
  2. lavage, vacuum assisted abdominal closure, third look 72 hours after emergency surgery

Within the study, data of DCS-procedures will be collected retrospectively in a multicentric and transnational approach. Those will be compared to a cohort of patients treated with a "no-DCS"-technique (resection with primary anastomosis or Hartmann´s procedure).


Condition or disease Intervention/treatment
Perforated Diverticulitis Procedure: Damage control strategy

Show Show detailed description

Layout table for study information
Study Type : Observational
Estimated Enrollment : 600 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Official Title: The Damage Control Strategy for the Treatment of Perforated Diverticulitis of the Sigmoid Colon With Diffuse Peritonitis - a Retrospective, Multicenter, Transnational Cohort Study
Actual Study Start Date : November 1, 2020
Estimated Primary Completion Date : December 1, 2023
Estimated Study Completion Date : June 1, 2024

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Study Group
All consecutive patients who underwent damage control surgery (DCS) for perforated diverticulitis of the sigmoid colon with generalized Peritonitis in one of the participating centers
Procedure: Damage control strategy

The damage control strategy constitutes a two stage procedure.

Emergency surgery:

limited resection oft he diseased colonic segment with oral and aboral blind closure, abdominal lavage, temporary vacuum assisted abdominal closure

Second look surgery (48-72 hours later):

reexploration with

  1. definite reconstruction (Colorectal anastomosis -/+ diverting ileostomy vs. end colostomy)
  2. lavage, vacuum assisted abdominal closure, third look 72 hours after emergency surgery

Control group
All consecutive patients who underwent other than DCS surgery (resection with primary anastomosis, Hartmann´s procedure, laparoscopic lavage) for perforated diverticulitis of the sigmoid colon with generalized Peritonitis in one of the participating centers which do not apply DCS routinely.
Procedure: Damage control strategy

The damage control strategy constitutes a two stage procedure.

Emergency surgery:

limited resection oft he diseased colonic segment with oral and aboral blind closure, abdominal lavage, temporary vacuum assisted abdominal closure

Second look surgery (48-72 hours later):

reexploration with

  1. definite reconstruction (Colorectal anastomosis -/+ diverting ileostomy vs. end colostomy)
  2. lavage, vacuum assisted abdominal closure, third look 72 hours after emergency surgery




Primary Outcome Measures :
  1. Stoma rate at the end of the index hospital stay [ Time Frame: 30 days after surgery for definite reconstruction ]
    rate of enterostomies (Loop ileostomy and end colostomy) at the end of the hospital stay, associated to the emergency operation


Secondary Outcome Measures :
  1. Stoma rate over the long term [ Time Frame: through study completion, an average of 1 year ]
    rate of enterostomies (Loop ileostomy and end colostomy) at the end of the follow-up

  2. 30-day Morbidity [ Time Frame: 30 days after surgery for definite reconstruction ]
    Morbidity assessed by the Clavien-Dindo classification

  3. 30-day Mortality [ Time Frame: 30 days after surgery for definite reconstruction ]
    Mortality



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All consecutive patients who underwent surgery for perforated diverticulitis of the sigmoid colon with generalized peritonitis will be included into the analysis
Criteria

Inclusion Criteria:

all patients who were operated for perforated diverticulitis with generalized peritonitis

Exclusion Criteria:

incomplete data sets


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04220840


Locations
Layout table for location information
Germany
Dr. Maximilian Sohn Recruiting
Munich, Bavaria, Germany, 81925
Contact: Maximilian Sohn, M.D., Dr. med.    +49-89-9270702756    maximilian.sohn@klinikum-muenchen.de   
Contact: Igors Iesalnieks, M.D., Prof. Dr. med.    +49-9270702125    igors.iesalnieks@klinikum-muenchen.de   
Sponsors and Collaborators
Städtisches Klinikum München GmbH
Charite University, Berlin, Germany
Medical University Innsbruck
University of Pisa
Cardarelli Hospital
Publications of Results:
Layout table for additonal information
Responsible Party: Dr. Maximilian Sohn, M.D., Dr. med., Attending Surgeon, Städtisches Klinikum München GmbH
ClinicalTrials.gov Identifier: NCT04220840    
Other Study ID Numbers: DCS-INT-2020
First Posted: January 7, 2020    Key Record Dates
Last Update Posted: September 8, 2023
Last Verified: September 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Peritonitis
Diverticulitis
Intraabdominal Infections
Infections
Peritoneal Diseases
Digestive System Diseases
Diverticular Diseases
Gastroenteritis
Gastrointestinal Diseases